🌟 Exciting news at #OneChain! We warmly welcome Irene, a recent PhD in Cancer Immunotherapy from CIMA. Her innovative research will enhance our team's efforts in #CancerResearch. 💪 Welcome, Irene! Learn more about her and our team here: onechaintx.com/team

Su proyecto investiga la aplicación de inmunoterapia celular adoptiva con Car-T para la leucemia linfoblástica aguda T cortical, evaluando la eficacia de una terapia que se dirige contra una nueva diana segura y sin apenas presencia en tejidos sanos. One Chain Immunotherapeutics 👉

🔬Asociación Española Contra el Cáncer is leading efforts to convert research into solutions that enhance patients' quality of life. At #OneChain, we're proud to be part of this ecosystem by developing a #CARTtherapy for an aggressive leukemia subtype, thanks to AECC IMPACT grant.

📣 Milestone Achieved! We've treated the first patient in our CARxALL trial with our most avanced product, OC-1. This marks a significant step forward in the fight against cortical T-cell acute lymphoblastic #leukemia More info here 👉 onechaintx.com/press/first-pa…

Kicking Off a Revolutionary Journey in Advanced Therapies! 🚀 On May 3rd, we hosted the kick-off meeting for the TransMisiones project at Parc Científic de Barcelona . Excited to innovate with AI for next-gen therapies! 🌟 More info: onechaintx.com/press/onechain…

🔬​ Excited to share a Fundación Botín article on our commitment to CAR T therapy and cancer treatment innovation! 🔗 Read about our journey, project progress, and crucial funding fundacionbotin.org/wp-content/upl…

Back on track! 🚀 🎉 We're thrilled to announce that OneChain Immunotherapeutics is featured in a new blog by the Asociación Española Contra el Cáncer, highlighting our innovative work in #CART immunotherapy for #leukemia 🔬 👉 Read the full blog: blog.contraelcancer.es/inmunoterapia-…

📢 We will be attending the #AdvancedTherapiesEurope conference on September 10-12th in Estoril, Portugal. Our CEO will be sharing his expertise on the future of funding #ATMPs. Looking forward to 3 days of interesting discussions and meetings! 🎉 👇…vancedtherapieseurope.phacilitate.com/?_gl=1%2Azdhsw…

🎗September is #Leukemia and #Lymphoma Awareness Month. We’re committed to innovate #CART cell therapies to bring new hope to patients battling blood cancers.🩸👩‍🔬 This month, and every month, we stand with the patients, families, and doctors in this fight. Thank you!🤝

📢Exciting news! The 9th CAR-TCR Summit is happening from September 17-20th in Boston, USA. We'll be there discussing the achievements and future direction of #OneChainTherapeutics in #CART therapies and sharing updates on our CARxALL trial. Keep tuned for more! 🚀 👇

Today is #WorldCancerResearchDay!🎗️ Thank you to all researchers dedicated to advancing #cancer treatment for your unwavering commitment!💪 At OneChain Immunotherapeutics, we are proud to contribute through our groundbreaking #CART cell therapies onechaintx.com/pipeline🔬

💬Last Friday, we took part at the #CoffeeConnection event at Parc Científic de Barcelona . Our CEO, @StefanosTheoharis talked about all our scientific advancements in #CARTtherapies.🧬 What a pleasure to connect with other innovative companies at this insightful event! ​🙌

First day of the #FestivalofBiologics in Basel! 🎉 A key event for discussing the latest advancements in biologics and therapeutics. Our CEO, Stefanos Theoharis, will be speaking about our innovative #CART cell therapies and our vision for transforming #cancer treatment.🧬

📢 JOB OFFER | Our member One Chain Immunotherapeutics is looking for a Senior Grants and Project Manager 👉 ow.ly/kBwK50NnG6F #JobOffer #senior #manager #grants #projectmanager #jobs

Thrilled to see our latest study published! 🚀 We present a novel dual immunotherapy approach for T-ALL. Huge thanks to the amazing team Menendez Lab and all collaborators who made this possible, 🏳️‍🌈Toribio Lab🏳️‍⚧️ One Chain Immunotherapeutics and others! 🔗 link.springer.com/article/10.118…